Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PPD Australia is the Australian subsidiary of PPD, a leading global contract research organization (CRO) that is part of the clinical research business of Thermo Fisher Scientific. The company provides comprehensive drug development, laboratory, and lifecycle management services, supporting pharmaceutical, biotechnology, and medical device sponsors. In Australia and New Zealand, PPD operates with a team of approximately 450 professionals, leveraging local networks and global expertise to accelerate clinical trials from early development to late-phase studies. PPD Australia has extensive experience in navigating local regulatory pathways, including obtaining Genetically Modified Organism (GMO) licenses from the Office of the Gene Technology Regulator (OGTR) and managing Institutional Biosafety Committee (IBC) submissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PPD Australia.